FEBS Letters
Volume 583, Issue 7 , Pages 1102-1106, 2 April 2009

Leptin exerts an anti-apoptotic effect on human dendritic cells via the PI3K-Akt signaling pathway

Edited by Laszlo Nagy

Department of Therapeutic Research and Medicine Evaluation, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy

Received 18 December 2008; received in revised form 28 January 2009; accepted 22 February 2009. published online 27 February 2009.

Abstract 

Leptin is an adipocyte-derived hormone/cytokine that modulates immune responses. It induces functional and morphological changes in human dendritic cells (DCs), licensing them towards Th1 priming and promoting DC survival. Here we found that leptin protects DCs from spontaneous, UVB and H2O2-induced apoptosis, by triggering the activation of nuclear factor-kappa B (NF-kB) and a parallel up-regulation of bcl-2 and bcl-XL gene expression and Akt activation. We found that leptin activates the PI3K-Akt signaling pathway as demonstrated by the suppression of the effect of leptin on DC survival by wortmannin and API-2, which suppress the leptin-induced activation of Akt, NF-kB, bcl-2, bcl-XL and protection from apoptosis. These results provide insights on the immunoregulatory function of leptin, supporting a potential application in immunotherapeutic approaches.

Abbreviations: JAK, Janus kinase, MAPK, mitogen-activated protein kinase, NF-kB, nuclear factor-kappa B, PI3K, phosphatidylinositol 3-kinase, STAT, signal trasducers and activator of transcription

Keywords: Leptin, Apoptosis, Dendritic cell

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(09)00145-8

doi:10.1016/j.febslet.2009.02.029

FEBS Letters
Volume 583, Issue 7 , Pages 1102-1106, 2 April 2009